A comparison is being made between the stocks of two companies, Pfizer and Moderna, to determine which is the better investment option. The stocks are described as "beaten-down", suggesting they may have experienced a decline in value. The outcome of this comparison is not specified, with both Pfizer and Moderna being considered.